Virus News and Research

Latest Virus News and Research

Mortality risk higher among children with primary immunodeficiency diseases infected with SARS-CoV-2

Children with certain immunodeficiency diseases carry mutations in genes that regulate the body's immune system against viral infections and they have a higher mortality rate due to COVID-19.

16 Sep 2022

Mucus-based prophylactic gel protects against HIV and herpes transmission

A mucus-based prophylactic gel developed at KTH Royal Institute of Technology has proven 70 percent effective in lab tests against HIV, and 80 percent effective against herpes.

16 Sep 2022

U of A research findings could give scientists the upper hand in tackling SARS-CoV-2

University of Alberta research shows how cell membranes play a much larger role than previously understood in allowing spike proteins on viruses to infect cells.

16 Sep 2022

New genomic test can predict a patient's risk of developing severe COVID-19, research suggests

A genomic test being developed by a Charlottesville, Va., company can predict a patient's risk of developing severe COVID-19, new research from UVA Health suggests.

16 Sep 2022

Genomic sequencing reveals the course of COVID-19 in Africa

A new study explores the contribution of genomic sequencing to the scientific understanding of COVID-19, and on the introduction of global public health measures via the ability to pick up new variants early enough.

16 Sep 2022

SARS-CoV-2 N escape mutations do not affect rapid antigen testing

A new study maps the escape mutations found in various strains of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could cause them to escape neutralization by antibodies or detection by rapid antigen tests that rely on antibody binding for a positive result.

16 Sep 2022

SARS-CoV-2 infection and vaccination results in highest and longest-lasting antibody response

A prospective seroprevalence study in the Catalan population underlines the need to get vaccinated despite having been infected and confirms that hybrid immunity (vaccination plus infection) is more robust and long-lasting.

16 Sep 2022

Study evaluates how rapid tests will perform when challenged with future SARS-CoV-2 variants

The availability of rapid antigen tests has significantly advanced efforts to contain the spread of COVID-19, but every new variant of concern raises questions about whether diagnostic tests will still be effective.

15 Sep 2022

Disruption of actin cytoskeleton is key to triggering human immune response, research finds

Researchers from Cleveland Clinic's Florida Research and Innovation Center (FRIC) found that disruption of a cellular structure, known as the actin cytoskeleton, is a "priming signal" for the body to respond to a virus.

15 Sep 2022

New method evaluates how mutations to SARS-CoV-2 can affect antibody recognition in rapid antigen tests

A research team funded by the National Institutes of Health has shown that commercially available rapid antigen tests can detect past and present variants of concern and has identified potential mutations that may impact test performance in the future.

15 Sep 2022

KHN’s ‘What the Health?’: Graham’s bill recenters abortion debate

Sen. Lindsey Graham (R-S.C.) put abortion back on Republicans' agenda this week with a legislative proposal calling for a national ban on most abortions after 15 weeks of pregnancy.

15 Sep 2022

New immunotherapy approach may lead to an effective treatment for fibrosis

Chronic diseases often lead to fibrosis, a condition in which organ tissue suffers from excessive scarring.

15 Sep 2022

BU researcher awarded $7.2 million grant to develop mAb-based contraceptive products

Deborah Jean Anderson, PhD, professor of medicine at Boston University School of Medicine, has received a four-year, $7.2 million grant from the NIH's National Institute of Child Health and Human Development renewing support for a Contraceptive Research Center at BUSM to further her research to develop innovative monoclonal antibody (mAb)-based contraceptive and multipurpose prevention technology (MPT) products.

15 Sep 2022

Survey highlights increase in the public's knowledge about monkeypox

The public's knowledge about monkeypox has increased rapidly in recent weeks though misconceptions and uncertainty persist, and over a quarter of Americans say they are not likely to get vaccinated against monkeypox if they're exposed to it, according to a new Annenberg Public Policy Center (APPC) survey.

15 Sep 2022

Virus News and Research

Latest Virus News and Research

Mortality risk higher among children with primary immunodeficiency diseases infected with SARS-CoV-2

Mucus-based prophylactic gel protects against HIV and herpes transmission

U of A research findings could give scientists the upper hand in tackling SARS-CoV-2

New genomic test can predict a patient's risk of developing severe COVID-19, research suggests

Genomic sequencing reveals the course of COVID-19 in Africa

SARS-CoV-2 N escape mutations do not affect rapid antigen testing

SARS-CoV-2 infection and vaccination results in highest and longest-lasting antibody response

Study evaluates how rapid tests will perform when challenged with future SARS-CoV-2 variants

Disruption of actin cytoskeleton is key to triggering human immune response, research finds

New method evaluates how mutations to SARS-CoV-2 can affect antibody recognition in rapid antigen tests

KHN’s ‘What the Health?’: Graham’s bill recenters abortion debate

New immunotherapy approach may lead to an effective treatment for fibrosis

BU researcher awarded $7.2 million grant to develop mAb-based contraceptive products

Survey highlights increase in the public's knowledge about monkeypox

Study reveals pan-antiviral properties of PDC-109 bovine seminal plasma protein

What is the COVID-19 prevalence among neonates?

Development of improved monoclonal antibodies against SARS-CoV-2

Bivalent recombinant vaccine protects against SARS-CoV-2 and influenza in animal models

Vaccine-derived poliovirus 2 detected in environmental samples in the UK and USA

What is the effect of the Omicron variant on olfaction?

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in